Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Protox Therapeutics Inc T.PRX

TSX:PRX - Post Discussion

View:
Post by bioboy10 on Oct 08, 2009 4:02pm

News


Stock hanging in at around 0.53 cents. Cannacord selling. anyone have any interesting comments or hear anything?

ONC  had a decent pop on FDA approval. It is a comparable to PRX.
Comment by cabbieJBJ on Oct 08, 2009 7:48pm
I thought that I had seen something to the effect that the lead clinician on the 12 month study (I think it was this one) was to present the data at a conference somewhere in Europe around the beginning of November.  Nothing on the PRX website though.  Maybe a call to IR is in order regarding this and expected timeline for the Phase 2b.  It was expected to be quiet for a couple of ...more  
Comment by cabbieJBJ on Oct 08, 2009 7:54pm
Yes I was not imagining things.  It was in the Phase 2 PR:"Detailed 12-month results from this Phase 2 open-label clinical trial will be presented by Dr Pommerville at the 30th World Congress of the Societe Internationale d'Urologie to be held in Shanghai from November 1-5, 2009."The detail will hopefully add color to the results.  Another pop maybe.  Ideally, I'd ...more